Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry.

age variation short‐ and long‐term outcome takotsubo syndrome

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
13 Feb 2024
Historique:
medline: 13 2 2024
pubmed: 13 2 2024
entrez: 13 2 2024
Statut: aheadofprint

Résumé

The role of age in the short- and long-term prognosis of takotsubo syndrome (TTS) is controversial. The aim of the present study was to evaluate age-related differences and prognostic implications among patients with TTS. In total, 2492 consecutive patients with TTS enrolled in an international registry were stratified into 4 groups (<45, 45-64, 65-74, and ≥75 years). The median long-term follow-up was 480 days (interquartile range, 83-1510 days). The primary outcome was all-cause mortality (in-hospital and out-of-hospital mortality). The secondary end point was TTS-related in-hospital complications. Among the 2479 patients, 58 (2.3%) were aged <45 years, 625 (25.1%) were aged 45 to 64 years, 733 (29.4%) were aged 65 to 74 years, and 1063 (42.6%) were aged ≥75 years. Young patients (<45 years) had a higher prevalence of men (from youngest to oldest, 24.1% versus 12.6% versus 9.7% versus 11.4%; Young patients with TTS have a typical phenotype characterized by a higher prevalence of male sex, non-apical ballooning patterns, and in-hospital complications. However, in-hospital and long-term mortality are significantly lower in young patients with TTS. URL: https://classic.clinicaltrials.gov/ct2/show/NCT04361994. Unique identifier: NCT04361994.

Sections du résumé

BACKGROUND BACKGROUND
The role of age in the short- and long-term prognosis of takotsubo syndrome (TTS) is controversial. The aim of the present study was to evaluate age-related differences and prognostic implications among patients with TTS.
METHODS AND RESULTS RESULTS
In total, 2492 consecutive patients with TTS enrolled in an international registry were stratified into 4 groups (<45, 45-64, 65-74, and ≥75 years). The median long-term follow-up was 480 days (interquartile range, 83-1510 days). The primary outcome was all-cause mortality (in-hospital and out-of-hospital mortality). The secondary end point was TTS-related in-hospital complications. Among the 2479 patients, 58 (2.3%) were aged <45 years, 625 (25.1%) were aged 45 to 64 years, 733 (29.4%) were aged 65 to 74 years, and 1063 (42.6%) were aged ≥75 years. Young patients (<45 years) had a higher prevalence of men (from youngest to oldest, 24.1% versus 12.6% versus 9.7% versus 11.4%;
CONCLUSIONS CONCLUSIONS
Young patients with TTS have a typical phenotype characterized by a higher prevalence of male sex, non-apical ballooning patterns, and in-hospital complications. However, in-hospital and long-term mortality are significantly lower in young patients with TTS.
REGISTRATION BACKGROUND
URL: https://classic.clinicaltrials.gov/ct2/show/NCT04361994. Unique identifier: NCT04361994.

Identifiants

pubmed: 38348805
doi: 10.1161/JAHA.123.030623
doi:

Banques de données

ClinicalTrials.gov
['NCT04361994']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e030623

Auteurs

Ibrahim El-Battrawy (I)

Institute of Physiology, Department of Cellular and Translational Physiology and Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology Ruhr University Bochum, Bochum, Germany Bochum Germany.
Department of Cardiology and Angiology Bergmannsheil University Hospitals, Ruhr University of Bochum Bochum Germany.

Francesco Santoro (F)

Department of Medical and Surgical Sciences University of Foggia Foggia Italy.

Iván J Núñez-Gil (IJ)

Interventional, Cardiology Cardiovascular Institute, Hospital Clínico Universitario San Carlos Madrid Spain.

Toni Pätz (T)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck University Heart Center Lübeck Lübeck Germany.

Luca Arcari (L)

Institute of Cardiology Madre Giuseppina Vannini Hospital Rome Italy.

Mohammad Abumayyaleh (M)

Institute of Physiology, Department of Cellular and Translational Physiology and Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology Ruhr University Bochum, Bochum, Germany Bochum Germany.
CIBERCV Madrid Spain.

Federico Guerra (F)

Cardiology and Arrhythmology Clinic Marche Polytechnic University, University Hospital "Umberto I-Lancisi-Salesi" Ancona Italy.

Giuseppina Novo (G)

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Cardiology Unit University of Palermo, University Hospital P. Giaccone Palermo Italy.

Beatrice Musumeci (B)

Cardiology, Clinical and Molecular Medicine Department, Faculty of Medicine and Psychology Sapienza University of Rome Rome Italy.

Luca Cacciotti (L)

Cardiology Unit Madre Giuseppina Vannini Hospital Rome Italy.

Enrica Mariano (E)

Division of Cardiology University of Rome Tor Vergata Rome Italy.

Pasquale Caldarola (P)

Department of Cardiology San Paolo Hospital Bari Italy.

Giuseppe Parisi (G)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital University of Catania Catania Italy.

Roberta Montisci (R)

Clinical Cardiology, Department of Medical Science and Public Health University of Cagliari Cagliari Italy.

Enrica Vitale (E)

Department of Medical and Surgical Sciences University of Foggia Foggia Italy.

Massimo Volpe (M)

Cardiology, Clinical and Molecular Medicine Department, Faculty of Medicine and Psychology Sapienza University of Rome Rome Italy.

Miguel Corbì-Pasqual (M)

Department of Cardiology Complejo Hospitalario de Albacete Albacete Spain.

Manuel Martinez-Selles (M)

Department of Cardiology Hospital General Universitario Gregorio Marañon, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares Madrid Spain.
Universidad Europea, Universidad Complutense Madrid Spain.

Manuel Almendro-Delia (M)

Servicio de Cardiología Hospital Virgen de la Macarena Sevilla Spain.

Alessandro Sionis (A)

Unidad de Cuidados Intensivos Cardiológicos, Servicio de Cardiología, Hospital de Sant Pau, Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau) Barcelona Spain.

Aitor Uribarri (A)

Cardiology Service, Vall d'Hebron University Hospital Barcelona Spain.
CIBERCV Madrid Spain.

Holger Thiele (H)

Department of Internal Medicine/Cardiology Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute Leipzig Germany.

Natale Daniele Brunetti (ND)

Department of Medical and Surgical Sciences University of Foggia Foggia Italy.

Ingo Eitel (I)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck University Heart Center Lübeck Lübeck Germany.

Ibrahim Akin (I)

University of Mannheim Mannheim Germany.

Thomas Stiermaier (T)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck University Heart Center Lübeck Lübeck Germany.

Classifications MeSH